+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the safety, usability, implantation accuracy, and effectiveness of the MINIject S device in people with open angle glaucoma. This international, multi-center study has two parts the first part compares three different investigational insertion tools to find the best one for placing the MINIject implant. In the second part, the chosen insertion tool is tested in a larger group of patients with both open angle glaucoma and operable cataracts undergoing combined glaucoma and cataract surgery. Participants will receive the MINIject S implant placed in the supraciliary space using one of the investigational insertion tools. In Part 1, each group will use a different version of the insertion tool, with both participants and central readers unaware of which tool is used to ensure unbiased results. In Part 2, the selected insertion tool from Part 1 will be used during combined glaucoma and cataract surgery with intraocular lens implantation. During the study, participants will undergo various assessments including evaluation of correct device placement one week after surgery and ease of use during the procedure. Follow-up visits will occur at 6, 12, and 24 months to monitor visual acuity, intraocular pressure, corneal cell density, and any adverse events. Researchers will also track the need for additional surgeries and changes in glaucoma medications. Participants are expected to adhere to study instructions and attend scheduled examinations throughout the trial, which runs until December 2028.

Age: 20Years +All GendersPhase Not Applicable
5 locations
S

Actively Recruiting

Researchers are evaluating a canaloplasty device for people with open-angle glaucoma undergoing cataract surgery. The study aims to assess the safety and effectiveness of this device in managing eye pressure in this condition. This first-in-human trial is conducted by New World Medical, Inc. and is designed to provide important information about this surgical system. Participants will be treated with a US FDA-approved canaloplasty device during their cataract surgery. The study focuses on how the device affects intraocular pressure IOP and the need for IOP-lowering medications over time. There is one treatment group involving the use of this canaloplasty and trabeculotomy surgical system. During the study, participants will have their intraocular pressure measured, with the main outcome being the change in IOP one year after surgery. Researchers will also monitor IOP levels and medication use at 12 months. The study begins in September 2025 and continues through October 2027, involving regular follow-up visits to track safety and effectiveness results.

Age: 22Years +All GendersPhase Not Applicable
3 locations